Make your money go further for just 25p per day

AIM IHT

Part 1 of our pick of the most exciting AIM arrivals in 2021

21/12/2021 · AMTE Power (AMTE)  · Belluscura (BELL)  · Saietta Group (SED) 

AIM AIM Inheritance Tax potential IPOs Technology

Baby

With plenty of technological innovation, addressing key issues, this is the first part of our selection of some of AIM's brightest new arrivals in 2021. They could bring plenty of excitement to investors over the long term. (Free to read)


Research from AIM specialists Fundamental Asset Management* reveals that 2021 is the first year since 2014 that Initial public Offerings (‘IPOs’) on London’s AIM market have exceeded cancellations.

By the end of November AIM had attracted a total 75 new issues in 2021, while over the same period only 51 companies cancelled their admission. That’s a welcome change for AIM, where, since 2014, delistings have significantly exceeded new issues. This has seen the number of companies…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on AMTE Power

Part 1 of our pick of the most exciting AIM arrivals in 2021

21/12/2021 · Company Insights

With plenty of technological innovation, addressing key issues, this is the first part of our selection of…


Energy transition - a big investment opportunity

17/12/2021 · Company Insights

Updates covered here include those from several fast-growing companies operating at the heart of energy transition. This…


More on Belluscura

Impairments | Dividend reinstatement | Bonkers Bargain

16/08/2023 · Company Insights

News covered here include disappointing results from another company following a buy and build strategy, although…


AIM Innovators: Creo Medical initiates partnership strategy

24/01/2022 · Company Insights

Sign-up to our free email updates

SIGN UP